Near-infrared fluorescent RGD peptides for optical imaging of integrin αvβ3 expression in living mice

Bioconjugate Chemistry

Volumn 16, Issue 6, 2005, Pages 1433-1441

  Cheng, Zhen ^a   Wu, Yun ^a   Xiong, Zhengming ^a,b   Gambhir, Sanjiv Sam ^a   Chen, Xiaoyuan ^a  

^a STANFORD UNIVERSITY   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; CELL CULTURE; CELL MEMBRANES; DIMERS; FLUORESCENCE IMAGING; INFRARED DEVICES; PEPTIDES; TUMORS;

FLUORESCENCE OPTICAL IMAGING; INTEGRINS; MONOMERICS; NEAR-INFRARED FLUORESCENCE; NEAR-INFRARED FLUORESCENT; NORMAL TISSUE; POST INJECTION; RGD PEPTIDE; TETRAMERIC; TETRAMERS;

MONOMERS;

ARGINYLGLYCYLASPARTIC ACID; CY5.5 DYE; CYANINE DYE; DIMER; FLUORESCENT DYE; MONOMER; PEPTIDE DERIVATIVE; TETRAMER; UNCLASSIFIED DRUG; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CANCER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER MODEL; CONTROLLED STUDY; DEVICE; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIMERIZATION; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG STRUCTURE; DRUG UPTAKE; EVALUATION; FEMALE; FLUORESCENCE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGING SYSTEM; MOUSE; NEAR INFRARED FLUORESCENCE OPTICAL IMAGING; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TUMOR XENOGRAFT;

ANIMALIA; MUS MUSCULUS;

EID: 27944452698     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc0501698     Document Type: Article

References (49)

1. Massoud, T. F., and Gambhir, S. S. (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev. 17, 545-80.
2. Sevick-Muraca, E. M., Houston, J. P., and Gurfinkel, M. (2002) Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr. Opin. Chem. Biol. 6, 642-50.
3. Ntziachristos, V., Bremer, C., and Weissleder, R. (2003) Fluorescence imaging with near- infrared light: new technological advances that enable in vivo molecular imaging. Eur. Radiol. 13, 195-208.
4. Tung, C. H. (2004) Fluorescent peptide probes for in vivo diagnostic imaging. Biopolymers 76, 391-403.
5. Weissleder, R., and Mahmood, U. (2001) Molecular imaging. Radiology 219, 316-33.
6. Weissleder, R., Tung, C. H., Mahmood, U., and Bogdanov, A., Jr. (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat. Biotechnol. 17, 375-8.
7. Tung, C. H., Mahmood, U., Bredow, S., and Weissleder, R. (2000) In vivo imaging of proteolytic enzyme activity using a novel molecular reporter. Cancer Res. 60, 4953-8.
8. Tung, C. H., Zeng, Q., Shah, K, Kim, D. E., Schellingerhout, D., and Weissleder, R. (2004) In Vivo Imaging of β-Galactosidase Activity Using Far Red Fluorescent Switch. Cancer Res. 64, 1579-83.
9. Wunder, A., Tung, C. H., Muller-Ladner, U., Weissleder, R., and Mahmood, U. (2004) In vivo imaging of protease activity in arthritis: a novel approach for monitoring treatment response. Arthritis Rheum. 50, 2459-65.
10. Mahmood U., and Weissleder, R. (2003) Near-Infrared Optical Imaging of Proteases in Cancer. Mol. Cancer Ther. 2, 489-496.
11. Ke, S., Wen, X., Gurfinkel, M., Charnsangavej, C., Wallace, S., Sevick-Muraca, E. M., and Li, C. (2003) Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res. 63, 7870-5.
12. Moon, W. K., Lin, Y., O'Loughlin, T., Tang, Y., Kim, D. E, Weissleder, R., and Tung, C. H. (2003) Enhanced tumor detection using a folate receptor-targeted near-infrared fluorochrome conjugate. Bioconjugate Chem. 14, 539-45.
13. Licha, K., Hessenius, C., Becker, A., Henklein, P., Bauer, M., Wisniewski, S., Wiedenmann, and B., Semmler, W. (2001) Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes. Bioconjugate Chem. 12, 44-50.
14. Achilefu, S., Jimenez, H. N., Dorshow, R. B., Bugaj, J. E., Webb, E. G., Wilhelm, R. R., Rajagopalan, R., Johler, J., and Erion, J. L. (2002) Synthesis, in vitro receptor binding, and in vivo evaluation of fluorescein and carbocyanine peptide-based optical contrast agents. J. Med. Chem. 45, 2003-15.
15. Achilefu, S., Dorshow, R. B., Bugaj, J. E., and Rajagopalan, R. (2000) Novel receptor-targeted fluorescent contrast agents for in vivo tumor imaging. Invest. Radiol. 35, 479-85.
16. Bugaj, J. E., Achilefu, S., Dorshow, R. B., and Rajagopalan, R. (2001) Novel fluorescent contrast agents for optical imaging of in vivo tumors based on a receptor- targeted dye-peptide conjugate platform. J. Biomed. Opt. 6, 122-133.
17. Moore, A., Medarova, Z., Potthast, A., and Dai, G. (2004) In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res. 64, 1821-7.
18. Ballou, B., Fisher, G. W., Hakala, T. R., and Farkas, D. L. (1997) Tumor detection and visualization using cyanine fluorochrome-labeled antibodies. Biotechnol. Prog. 13, 649-58.
19. Zaheer, A., Lenkinski, R. E., Mahmood, A., Jones, A. G., Cantley, L. C, and Frangioni, J. V. (2001) In vivo near-infrared fluorescence imaging of osteoblastic activity. Nat. Biotechnol. 19, 1148-54.
20. Ntziachristos, V., Schellenberger, E. A., Ripoll, J., Yessayan, D., Graves, E., Bogdanov, A., Jr., Josephson, L., and Weissleder R. (2004) Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. Proc. Natl. Acad. Sci. U.S.A. 101, 12294-9.
21. Jin, H., and Varner, J. (2004) Integrins: roles in cancer development and as treatment targets. Br. J. Cancer 90, 561-5.
22. Cairns, R. A., Khokha, R., and Hill, R. P. (2003) Molecular mechanisms of tumor invasion and metastasis: an integrated view. Curr. Mol. Med. 3, 659-71.
23. Felding-Habermann, B. (2003) Integrin adhesion receptors in tumor metastasis. Clin. Exp. Metastasis 20, 203-13.
24. 3-targeted paramagnetic nanoparticles. Magn. Reson. Med. 53, 621-7.
25. 3. Circulation 108, 336-41.
26. 3-integrins. Circulation 107, 455-60.
27. 3-expressing cells. Mol. Imaging 3, 125-34.
28. 3 in brain tumor xenografts. Cancer Res. 64, 8009-14.
29. 3 in human tumor xenografts. Mol. Imaging 3, 343-51.
30. Achilefu, S., Bloch, S., Markiewicz, M. A., Zhong, T., Ye, Y., Dorshow, R. B., Chance, B., and Liang, K. (2005) Synergistic effects of light-emitting probes and peptides for targeting and monitoring integrin expression. Proc. Natl. Acad. Sci. U.S.A. 102, 7976-81.
31. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl. Med. Biol. 31, 179-89.
32. 3 -integrin expression. J. Nucl. Med. 45, 1776-83.
33. 64Cu-labeled RGD peptide. Bioconjug. Chem. 15, 41-9.
34. 18F-labeled PEGylated RGD peptide. Eur. J. Nucl. Med. Mol. Imaging 31, 1081-9.
35. 3 -targeted imaging of lung cancer Neoplasia 7, 271-9.
36. 18F-labeled dimeric RGD peptide. Mol. Imaging 3, 96-104.
37. 64Cu-labeled dimeric RGD peptides. Mol. Imaging Biol. 6, 350-9.
38. 18F]Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates. Bioconjugate Chem. 15, 61-9.
39. 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res. 61, 1781-5.
40. 18F]Galacto-RGD. PLoS Med. 2, 0244-51.
41. 3 integrin in vivo. Circulation 110, 84-90.
42. Meoli, D. F., Sadeghi, M. M., Krassilnikova, S., Bourke, B. N., Giordano, F. J., Dione, D. P., Su, H., Edwards, D. S., Liu, S., Harris, T. D., Madri, J. A., Zaret, B. L., and Sinusas, A. J. (2004) Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J. Clin. Invest. 113, 1684-91.
43. Janssen, M., Oyen, W. J., Massuger, L. F., Frielink, C., Dijkgraaf, I., Edwards, D. S., Radjopadhye, M., Corstens, F. H., and Boerman, O. C. (2002) Comparison of a Monomeric and dimeric radiolabeled RGD-peptide for tumor targeting. Cancer Biother. Radiopharm. 17, 641-6.
44. 3 integrin binding peptides in a nude mouse model. Cancer Res. 62, 6146-51.
45. 125I-labeled RGD peptide are improved by PEGylation. Nucl. Med. Biol. 31, 11-9.
46. 64Cu Labeled Tetrameric RGD Peptide. J. Nucl. Med. 46, 1707-18.
47. Nakayama, A., del Monte, F., Hajjar, R. J., and Frangioni, J. V. (2002) Functional near-infrared fluorescence imaging for cardiac surgery and targeted gene therapy. Mol. Imaging 1, 365-77.
48. 3 in complex with an Arg-Gly-Asp ligand. Science 296, 151-5.
49. Gao, X., and Nie, S. (2005) Quantum dot-encoded beads. Methods Mol. Biol. 303, 61-72.